Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 05 2021
Historique:
received: 21 09 2020
accepted: 25 03 2021
entrez: 22 5 2021
pubmed: 23 5 2021
medline: 4 11 2021
Statut: epublish

Résumé

Systemic sclerosis (SSc) is a potentially serious and disabling connective tissue disease specially in case of interstitial lung disease (SSc-ILD). The aim of our study was to evaluate the potential utility of dosing in the induced sputum (IS) and to compare their levels in SSc-ILD and SSc-nonILD patients, as well as in healthy volunteers (HV). IS and sera values were also compared. In a prospective cross-sectional analysis, we studied the IS and serum provided from 25 SSc patients, 15 SSc-nonILD and 10 SSc-ILD, compared to 25 HV. We analyzed sputum cell composition and quantified in the supernatant and corresponding serum by commercially available immunoassays: IGFBP-1, IGFBP-2, IGFBP-3, TGF-β, IL-8, TNF-α, YKL-40, MMP-7 and MMP-9. Lung function was studied by the determination of FEV-1 (%), FVC (%), DLCO (%) and KCO (%). The IS of SSc patients had a lower weight than HV (p<0.05, p<0.01) without any significant difference with regard to the cellularity. IGFBP-1 (p < 0.0001), TGF-β (p < 0.05), IL-8 (p < 0.05), YKL-40 (p < 0.0001) and MMP-7 (p < 0.01) levels were increased in the IS of SSc patients compared to HV. Only IL-8 serum levels (p < 0.001) were increased in SSc patients compared to HV. Neither in IS nor in serum were observed differences between SSc-ILD and SSc-nonILD patients. Correlations were observed between IS IL-8 levels and FEV-1 (%) (r =  = - 0.53, p < 0.01), FVC (%) (r = - 0.51, p < 0.01) and annualized ∆KCO (%) (r = 0.57, p < 0.05), between IS TGF-β levels and annualized ∆FEV-1 (%) (r =  = - 0.57, p < 0.05), between IS IGFBP-2 levels and annualized ∆KCO (%) (r = 0.56, p < 0.05). Our study showed that SSc patients exhibit raised IS levels of IGFBP-1, TGF-β, IL-8, YKL-40 and MMP-7, molecules known to be involved in lung remodeling and fibrotic process, without any significant difference between SSc-ILD and SSc-nonILD patients. IL-8, TGF-β and IGFBP-2 are correlated with lung function in SSc patients which emphasize clinical relevance. IS analysis represents a new approach to understand lung inflammatory process in SSc patients. A longitudinal study is needed to evaluate their pathophysiological relevance.

Identifiants

pubmed: 34021175
doi: 10.1038/s41598-021-87701-1
pii: 10.1038/s41598-021-87701-1
pmc: PMC8139955
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Inflammation Mediators 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10679

Références

Oncogene. 2009 Dec 17;28(50):4456-68
pubmed: 19767768
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Respir Med. 2011 Jan;105(1):106-13
pubmed: 20888745
Rheumatology (Oxford). 2019 Sep 1;58(9):1534-1546
pubmed: 31292645
Arthritis Rheum. 2000 Feb;43(2):444-51
pubmed: 10693887
Respir Care. 2016 Oct;61(10):1369-73
pubmed: 27274093
Int J Mol Sci. 2020 May 19;21(10):
pubmed: 32438606
Thorax. 1992 Sep;47(9):738-42
pubmed: 1440471
Chest. 2020 Aug;158(2):646-659
pubmed: 32268131
Respir Med. 2010 Aug;104(8):1204-10
pubmed: 20347285
J Vis Exp. 2017 Dec 17;(130):
pubmed: 29286433
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
Rheumatol Int. 2012 Jul;32(7):1921-5
pubmed: 21448645
Arthritis Res Ther. 2009;11(4):R111
pubmed: 19615053
J Cell Commun Signal. 2015 Jun;9(2):125-42
pubmed: 25617050
Arthritis Rheum. 2007 Jun;56(6):2005-12
pubmed: 17530640
Radiology. 1990 Sep;176(3):755-9
pubmed: 2389033
Eur Respir J. 2017 Feb 23;49(2):
pubmed: 27836954
Chest. 2009 Nov;136(5):1211-1219
pubmed: 19429720
Atherosclerosis. 2010 Jun;210(2):590-5
pubmed: 20056225
Rheum Dis Clin North Am. 2015 May;41(2):237-48
pubmed: 25836640
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):55-61
pubmed: 24751454
Am J Respir Crit Care Med. 1995 Jul;152(1):53-8
pubmed: 7599862
Eur Respir J. 2005 Nov;26(5):948-68
pubmed: 16264058
Curr Opin Rheumatol. 2005 Nov;17(6):737-45
pubmed: 16224252
Exp Dermatol. 2011 Sep;20(9):770-3
pubmed: 21707759
Chest. 2008 May;133(5):1101-6
pubmed: 18071010
Arthritis Rheumatol. 2014 Aug;66(8):1967-78
pubmed: 24838199
Eur Respir J. 2010 Jan;35(1):112-7
pubmed: 19541715
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):762-8
pubmed: 9517588
Sarcoidosis Vasc Diffuse Lung Dis. 2003 Jun;20(2):138-43
pubmed: 12870724
Med Sci (Paris). 2016 Feb;32(2):183-91
pubmed: 26936176
Respiration. 2009;78(1):56-62
pubmed: 18931474
BMC Pediatr. 2018 Dec 4;18(1):381
pubmed: 30514252
Rev Med Liege. 2019 Jan;74(1):47-53
pubmed: 30680974
BMC Pulm Med. 2016 May 23;16(1):86
pubmed: 27215343
J Rheumatol. 2001 Jul;28(7):1573-6
pubmed: 11469464
Lung. 2017 Jun;195(3):273-280
pubmed: 28353114
PLoS One. 2017 Feb 8;12(2):e0171344
pubmed: 28178340
Proc Am Thorac Soc. 2012 Jul;9(3):111-6
pubmed: 22802283
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):228-36
pubmed: 26422568
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Rev Med Liege. 2019 Mar;74(3):139-145
pubmed: 30897313
PLoS One. 2016 May 09;11(5):e0154516
pubmed: 27159038
Int J Mol Sci. 2017 Dec 16;18(12):
pubmed: 29258183
Lab Invest. 1999 Nov;79(11):1403-13
pubmed: 10576211
Semin Arthritis Rheum. 2010 Feb;39(4):269-77
pubmed: 18706680
J Rheumatol. 2016 Sep;43(9):1672-9
pubmed: 27370878
N Engl J Med. 2019 Jun 27;380(26):2518-2528
pubmed: 31112379
Lancet Respir Med. 2020 May;8(5):453-460
pubmed: 32145830
Int J Chron Obstruct Pulmon Dis. 2018 Jan 30;13:409-418
pubmed: 29430175
Arthritis Rheum. 2009 Feb;60(2):569-77
pubmed: 19180517
Rev Med Liege. 2020 May;75(5-6):344-349
pubmed: 32496677
Chest. 2008 Sep;134(3):601-605
pubmed: 18403656
Gen Comp Endocrinol. 2005 May 15;142(1-2):44-52
pubmed: 15862547
Ann Rheum Dis. 2003 Feb;62(2):97-9
pubmed: 12525376
Am J Respir Crit Care Med. 2005 Aug 1;172(3):268-79
pubmed: 15879420
Clin Epigenetics. 2017 Aug 15;9:84
pubmed: 28824731
Ann Rheum Dis. 2008 Jan;67(1):110-6
pubmed: 17557890
Arthritis Rheum. 2007 Mar 15;57(2):318-26
pubmed: 17330281
J Clin Endocrinol Metab. 2011 Jan;96(1):200-9
pubmed: 20943784

Auteurs

P Jacquerie (P)

Rheumatology Department, CHU Liège, GIGA Research, ULiège, University Hospital of Liege, Domaine Universitaire du Sart-Tilman, B35, 4020, Liège, Belgium. pjacquerie@chuliege.be.

M Henket (M)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

B André (B)

Rheumatology Department, CHU Liège, GIGA Research, ULiège, University Hospital of Liege, Domaine Universitaire du Sart-Tilman, B35, 4020, Liège, Belgium.

C Moermans (C)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

D de Seny (D)

Rheumatology Department, CHU Liège, GIGA Research, ULiège, University Hospital of Liege, Domaine Universitaire du Sart-Tilman, B35, 4020, Liège, Belgium.

F Gester (F)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

R Louis (R)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

M Malaise (M)

Rheumatology Department, CHU Liège, GIGA Research, ULiège, University Hospital of Liege, Domaine Universitaire du Sart-Tilman, B35, 4020, Liège, Belgium.

J Guiot (J)

Pneumology Department, CHU Liège, GIGA Research, ULiège, Domaine Universitaire Sart Tilman, Liège, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH